Delving into the Latest Updates on Artisan Pharma, Inc. with Synapse

概览

关联

2

项与 Artisan Pharma, Inc. 相关的临床试验

EUCTR2007-002035-81-BE

/ Not yet recruitingN/A

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects with Sepsis and Disseminated Intravascular Coagulation

开始日期2007-09-10

申办/合作机构

Artisan Pharma, Inc.

NCT00487656

/ Completed临床2期

A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation

The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin) decreases the number of people who die as a result of Disseminated Intravascular Coagulation (DIC) complication of sepsis.

开始日期2007-07-01

申办/合作机构

Artisan Pharma, Inc.

100 项与 Artisan Pharma, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Artisan Pharma, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Artisan Pharma, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Artisan Pharma, Inc. 相关的转化医学

登录后查看更多信息